# Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer

> clinical trial · VERIFIED · 2026-07-21

Status: ACTIVE_NOT_RECRUITING · Sponsor: National Cancer Institute (NCI) · Condition: Breast Ductal Carcinoma In Situ

- Company: National Cancer Institute (NCI)
- Sector: Breast Ductal Carcinoma In Situ
- Primary source: https://clinicaltrials.gov/study/NCT01272037

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.